Article
Is biomarker research advancing in the era of personalized medicine for head and neck cancer?
International journal of clinical oncology - 1 Apr 2014
Yokota Tomoya
Abstract excerpt
Recent progress in molecular biology and translational research has initiated an era of personalized medicine in head and neck clinical oncology. The genetic information defined by biomarker analysis in tumors and individuals is indispensable for the administration of molecular targeting agents. The epidermal growth factor receptor (EGFR) signaling pathway is an important therapeutic target in head and neck...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
